Hyperbaric Oxygen Therapy and Cancer Studies
Hyperbaric Oxygen Therapy (HBOT) delivers pure oxygen at elevated atmospheric pressure, significantly increasing oxygen levels in tissues and blood. Emerging scientific research suggests that this heightened oxygen environment may influence cancer cell behavior — affecting proliferation, triggering apoptosis, and potentially enhancing the effectiveness of conventional anticancer agents.
Literature Review
Featured Research Studies
1
Breast Cancer
Granowitz EV, Tonomura N, Benson RM, Katz DM, Band V, Makari-Judson GP, Osborne BA
Anticancer Res. 2005 Nov-Dec; 25(6B):3833–42
3
T-Leukemia · B-Myeloma
Chen YC, Chen SY, Ho PS, Lin CH, Cheng YY, Wang JK, Sytwu HK
Leuk Res. 2007 Jun; 31(6):805–15
4
Leukemia
Ohgami Y, Elstad CA, Chung E, Shirachi DY, Quock RM, Lai HC
Anticancer Res. 2010 Nov; 30(11):4467–70
5
Colorectal Cancer
Daruwalla J, Christophi C
Eur J Cancer. 2006; 42:3304–3311
6
Colorectal · Combination
Daruwalla J, Greish K, Nikfarjam M, Millar I, Malcontenti-Wilson C, Iyer AK, Christophi C
J Drug Target. 2007 Aug-Sep; 15(7-8):487–95
